Dyve Biosciences utilizes its innovative DMAX transdermal platform to effectively modulate pH levels for the targeted treatment of immunologic and oncologic diseases, advancing the healthcare technology, biotechnology, and pharmaceuticals sectors through cutting-edge scientific developments in life sciences.
Specialties
DMAX transdermal platform
pH modulation therapy
targeted immunologic treatments
oncologic disease management
advanced life sciences innovation
Products & Services
Transdermal Drug Delivery
pH Modulation Therapies
Immunologic Disease Treatments
Oncologic Disease Treatments
Healthcare Technology Solutions
Contact Information
No contact information available
Competitors & Similar Companies(9)
Dermavant Sciences
California, • United States • Biotechnology
Innovative immuno-dermatology treatments, Topical therapies for plaque psoriasis, Arylhydrocarbon receptor agonist research, Targeted therapies for chronic skin conditions, Breakthrough science in biotechnology
Dyve Biosciences utilizes its innovative DMAX transdermal platform to effectively modulate pH levels for the targeted treatment of immunologic and oncologic diseases, advancing the healthcare technology, biotechnology, and pharmaceuticals sectors through cutting-edge scientific developments in life sciences.
What are the social media links of Dyve Biosciences?